UK small-cap RNS · 22 Sep 2026
Every announcement of UK small & mid caps under £2bn. The ones that started or moved a situation are marked – a click opens it.
Key = all announcements except routine filings (voting rights, buybacks, holdings, director forms), plus the ones that are part of a situation. Not investment advice.
| Time | Company | Mcap ↕ | Type | Announcement | |
|---|---|---|---|---|---|
| 07:00 | PHSC PHSC | £0.8m | Trading update | Trading Update
The Board notes that the Group’s unaudited management accounts show revenues for the first four months to 31 July 2026 of the current financial year of approximately £1,152,000 - an increase of approximately 6.5% on the prior year’s £1,082,000. |
|
| 07:00 | SThree STEM | £358m | Upgrade / downgrade cycle | FY26 Q3 Trading Update
Positive new business trends drive continued sequential improvement in performance |
|
| 07:00 | SkinBioTherapeutics SBTX | £15m | New CEO / reset | Trading Statement
22 September 2026 – SkinBioTherapeutics plc, (AIM: SBTX), the life science business focused on skin health announces that both the former interim CEO, Rachel Parsonage and former acting Chair, Alyson Levett have agreed to make their roles permanent. |
|
| 07:00 | Porvair PRV | £391m | Upgrade / downgrade cycle | Nine Month Trading Update
Full year trading anticipated to be slightly ahead of expectations with Drache progressing well and the acquisition of GV Filtri completed |
|
| 07:00 | B.P. Marsh & Partners BPM | £245m | Capital return | Trading Update
"Growth across the portfolio maintained as a softening market creates opportunity" |